Shares of Panbela Therapeutics, Inc. (PBLA) are up 37% on Wednesday after the company divested certain assets in its eflornithine pediatric neuroblastoma program to a Kentucky-based specialty pharmaceutical company, US WorldMeds for $9.
White House Meeting Focuses on Improving Access to Overdose Reversal Medications miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The White House has urged U.S. drug manufacturers who currently have FDA-approved opioid overdose reversal medication products to increase access and affordability of these life-saving medicines to the public.
/PRNewswire/ The "Rare Neurological Disease Treatment Market - Growth, Trends, and Forecasts (2023-2028)" report has been added to ResearchAndMarkets.com s.
Some FARA experts warned that another defeat in a high-profile case like Barrack’s could have a chilling effect on DOJ’s renewed push to crack down on illegal foreign lobbying.